Skip to main content

Commentary: Improvement of Outcome for Treatment of “Restenosis-Prone” Vascular Lesions? Potential Impact of the Paclitaxel Dose on Late Lumen Loss in Porcine Peripheral Arteries

CardioVascular and Interventional Radiology volume 45, pages 1832–1833 (2022)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

References

  1. Katsanos K, Geisler BP, Garner AM, et al. Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK. BMJ Open. 2016;6: e011245. https://doi.org/10.1136/bmjopen-2016-011245.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Gemeinhardt O, Haase T, Schnorr B, Xie J, Löchel M, Schütt D, Mittag A, Haider W, Bettink S, Speck U, Tepe G, Improvement of outcome for treatment of 'restenosis-prone' vascular lesions? Potential impact of the paclitaxel dose on late lumen loss in porcine peripheral arteries. Cardiovasc Intervent Radiol. 2022;15 Sep 2022. https://doi.org/10.1007/s00270-022-03277-x. Online ahead of print

  3. Ruebben A, Boeing J, Weiss N. Drug-eluting balloon analysis. Interv Cardiol. 2011;6(1):56–7.

    Article  Google Scholar 

  4. Liistro F, Di Mario C. Paclitaxel-coated balloons in peripheral artery disease: How much is enough? Eur Heart J. 2020;41(27):2553–5.

    Article  PubMed  Google Scholar 

  5. https://www.gov.uk/drug-device-alerts/paclitaxel-drug-coated-balloons-dcbs-or-drug-eluting-stents-dess-reconfirmed-position-on-use-in-patients-with-intermittent-claudication-and-critical-limb-ischaemia

  6. https://www.fda.gov/medical-devices/cardiovascular-devices/paclitaxel-coated-balloons-and-stents-peripheral-arterial-disease#recommendations

Download references

Funding

This study/article was not supported by any funding.

Author information

Authors and Affiliations

  1. Sheffield Vascular Institute, Sheffield Teaching Hospitals, Herries Road, Sheffield, S5 7AU, UK

    Trevor Cleveland

Authors
  1. Trevor Cleveland
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Trevor Cleveland.

Ethics declarations

Conflict of interest

The author declares that he has no conflict of interest.

Human and Animal Participants

This article does not contain any studies with human participants or animals performed by any of the authors. Institutional review board (IRB) approval was not required for this article.

Informed Consent

For this type of study/article, informed consent is not required.

Consent for Publication

For this type of study/article, consent for publication is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Cleveland, T. Commentary: Improvement of Outcome for Treatment of “Restenosis-Prone” Vascular Lesions? Potential Impact of the Paclitaxel Dose on Late Lumen Loss in Porcine Peripheral Arteries. Cardiovasc Intervent Radiol 45, 1832–1833 (2022). https://doi.org/10.1007/s00270-022-03299-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-022-03299-5